Overview

A Dose-finding Study of JMKX003142 in Treatment of Renal Edema

Status:
RECRUITING
Trial end date:
2026-07-30
Target enrollment:
Participant gender:
Summary
To Evaluate the Safety, Efficacy, and Pharmacokinetic Characteristics of JMKX003142 Administered Randomly, Open-label, Active-controlled Study in Chinese Renal Edema Patients.
Phase:
PHASE2
Details
Lead Sponsor:
Jemincare
Treatments:
Torsemide